Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease

We analyzed outcomes for 668 patients who had systemic treatment for chronic graft-versus-host disease (GVHD) to assess the utility of early treatment change for exacerbation of chronic GVHD as a surrogate for survival endpoints in clinical trials. Fifty-six percent of patients had treatment change...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Flowers, Mary E.D., Storer, Barry, Carpenter, Paul, Rezvani, Andrew, Vigorito, Afonso C., Campregher, Paulo V., Moravec, Carina, Kiem, Hans-Peter, Fero, Matthew, Georges, George, Warren, Edus, Lee, Stephanie, Sanders, Jean E., Appelbaum, Fred, Martin, Paul J.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2810860/
https://ncbi.nlm.nih.gov/pubmed/19041060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.09.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars